CHEMMART PERINDOPRIL ARGININE perindopril arginine 10 mg tablet blister pack Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

chemmart perindopril arginine perindopril arginine 10 mg tablet blister pack

arrotex pharmaceuticals pty ltd - perindopril arginine, quantity: 10 mg - tablet, film coated - excipient ingredients: brilliant blue fcf aluminium lake; isomalt; titanium dioxide; hypromellose; hyprolose; iron oxide yellow; magnesium stearate; colloidal anhydrous silica; macrogol 8000 - treatment of hypertension and the treatment of heart failure. in such patients it is recommended that perindopril arginine be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

TERRY WHITE CHEMISTS PERINDOPRIL ARGININE perindopril arginine 10 mg tablet blister pack Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

terry white chemists perindopril arginine perindopril arginine 10 mg tablet blister pack

arrotex pharmaceuticals pty ltd - perindopril arginine, quantity: 10 mg - tablet, film coated - excipient ingredients: magnesium stearate; macrogol 8000; iron oxide yellow; brilliant blue fcf aluminium lake; hypromellose; hyprolose; isomalt; colloidal anhydrous silica; titanium dioxide - treatment of hypertension and the treatment of heart failure. in such patients it is recommended that perindopril arginine be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

APOTEX-PERINDOPRIL ARGININE perindopril arginine 10 mg tablet blister pack Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

apotex-perindopril arginine perindopril arginine 10 mg tablet blister pack

arrotex pharmaceuticals pty ltd - perindopril arginine, quantity: 10 mg - tablet, film coated - excipient ingredients: brilliant blue fcf aluminium lake; macrogol 8000; iron oxide yellow; titanium dioxide; isomalt; colloidal anhydrous silica; hyprolose; hypromellose; magnesium stearate - treatment of hypertension and the treatment of heart failure. in such patients it is recommended that perindopril arginine be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

APX-PERINDOPRIL ARGININE perindopril arginine 5 mg tablet bottle Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

apx-perindopril arginine perindopril arginine 5 mg tablet bottle

servier laboratories (aust) pty ltd - perindopril arginine, quantity: 5 mg - tablet, film coated - excipient ingredients: magnesium stearate; hydrophobic colloidal silica anhydrous; macrogol 6000; sodium starch glycollate; maltodextrin; lactose monohydrate; colour - apx-perindopril arginine is indicated for: the treatment of hypertension; and the treatment of heart failure. in such patients it is recommended that apx-perindopril arginine be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of apx-perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

APX-PERINDOPRIL ARGININE perindopril arginine 2.5 mg tablet bottle Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

apx-perindopril arginine perindopril arginine 2.5 mg tablet bottle

servier laboratories (aust) pty ltd - perindopril arginine, quantity: 2.5 mg - tablet, film coated - excipient ingredients: hydrophobic colloidal silica anhydrous; magnesium stearate; sodium starch glycollate; macrogol 6000; lactose monohydrate; maltodextrin; colour - apx-perindopril arginine is indicated for: the treatment of hypertension; and the treatment of heart failure. in such patients it is recommended that apx-perindopril arginine be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of apx-perindopril arginine has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

COVERSYL 5 perindopril arginine 5 mg tablet bottle Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

coversyl 5 perindopril arginine 5 mg tablet bottle

servier laboratories (aust) pty ltd - perindopril arginine, quantity: 5 mg - tablet, film coated - excipient ingredients: maltodextrin; macrogol 6000; lactose monohydrate; hydrophobic colloidal silica anhydrous; magnesium stearate; sodium starch glycollate; colour - coversyl is indicated for: the treatment of hypertension; and the treatment of heart failure. in such patients it is recommended that coversyl be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of coversyl has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

COVERSYL 2.5 perindopril arginine 2.5 mg tablet bottle Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

coversyl 2.5 perindopril arginine 2.5 mg tablet bottle

servier laboratories (aust) pty ltd - perindopril arginine, quantity: 2.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; sodium starch glycollate; magnesium stearate; maltodextrin; hydrophobic colloidal silica anhydrous; macrogol 6000; colour - coversyl is indicated for: the treatment of hypertension; and the treatment of heart failure. in such patients it is recommended that coversyl be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of coversyl has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

PREXUM 5 perindopril arginine 5 mg film-coated tablet bottle Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

prexum 5 perindopril arginine 5 mg film-coated tablet bottle

servier laboratories (aust) pty ltd - perindopril arginine, quantity: 5 mg - tablet, film coated - excipient ingredients: maltodextrin; hydrophobic colloidal silica anhydrous; lactose monohydrate; macrogol 6000; sodium starch glycollate; magnesium stearate; colour - prexum is indicated for: the treatment of hypertension; and the treatment of heart failure. in such patients it is recommended that prexum be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of prexum has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

PREXUM 2.5 perindopril arginine 2.5 mg film-coated tablet bottle Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

prexum 2.5 perindopril arginine 2.5 mg film-coated tablet bottle

servier laboratories (aust) pty ltd - perindopril arginine, quantity: 2.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; maltodextrin; sodium starch glycollate; macrogol 6000; hydrophobic colloidal silica anhydrous; colour - prexum is indicated for: the treatment of hypertension; and the treatment of heart failure. in such patients it is recommended that prexum be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of prexum has not been demonstrated for new york heart association category iv patients); and patients with established coronary artery disease (see clinical trials) who are stable on concomitant therapy and have no heart failure, to reduce the risk of non-fatal myocardial infarction or cardiac arrest.

PERINDOPRIL/AMLODIPINE ACTAVIS 10/10 perindopril arginine 10 mg/amlodipine 10 mg tablet bottle Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

perindopril/amlodipine actavis 10/10 perindopril arginine 10 mg/amlodipine 10 mg tablet bottle

medis pharma pty ltd - amlodipine besilate, quantity: 13.88 mg; perindopril arginine, quantity: 10 mg - tablet - excipient ingredients: light magnesium oxide; crospovidone; microcrystalline cellulose; trehalose dihydrate; magnesium stearate; sodium starch glycollate; glycerol dibehenate; calcium hydrogen phosphate - perindopril/amlodipine is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.